

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1507, 2005-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)
Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. :


Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)
Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. :


Chronic obstructive pulmonary disease (COPD) may represent a serious threat
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. :

